News
Named for four consecutive years | Warmest congratulations to Wanbang Xinnuokang® Ginkgo Leaf Droplets for making it onto the "2023 China Pharmaceutical Brand List"!
Date:
01 Jul,2023
The 2023 China Pharmaceutical Industry Summit was grandly held from June 27 to 30 in Huzhou, China. This year’s conference, themed "Quality Wins: Navigating a New Cycle," brought together the strength and wisdom of China’s pharmaceutical and healthcare industry to deeply explore the current state and future prospects of the sector, sparking fresh ideas, guiding participants through the evolving market landscape, and jointly shaping a brighter tomorrow. During the event, the highly anticipated "2023 China Pharmaceutical Brand Rankings" were unveiled with great fanfare on the evening of June 29.
Wanbande Pharmaceutical Group's Key Products Wanbang Xinnaokang® Ginkgo Leaf Dropping Pills has proudly made it onto the 2023 China Pharmaceutical Brand List—specifically, the hospital-end list for cardiovascular and cerebrovascular disease medications (traditional Chinese medicine)! This marks the fourth consecutive year since 2020 that Wanbang Xinnuokang® Ginkgo Leaf Droplets have been proudly listed!
The "China Pharmaceutical Brand Ranking" is divided into three lists: "Hospital Endpoints," "Primary Care Endpoints," and "Retail Endpoints." Based on sales figures and growth rates of products across these three endpoints over the past three years, as tracked by the "Three Major Endpoints and Six Key Markets" monitoring system, brands are rigorously selected to make the shortlist for each category.
The primary criteria for being selected for the "2023 China Pharmaceutical & Brand Ranking" are:
1) The product's sales revenue and growth trajectory across the three major distribution channels over the past three years (2020–2022)—specifically, quantitative data from these channels reflecting the definitive demand driven by clinicians and consumers—will be analyzed through rigorous statistical methods, accounting for 60% of the evaluation.
2) From May 15 to May 21, 2023, the final list of top-ranked brands was selected through a WeChat vote for the "2023 China Pharmaceutical Brand List" published by Mene Network, accounting for 40% of the overall weighting.
3) For each category, the top 40% of brands will be selected based on their total scores to make the final shortlist.
The inclusion of Wanbang Xinnuokang® Ginkgo Leaf Droplets on the prestigious list is undoubtedly a strong testament to the product's outstanding performance in hospital settings, earning high recognition from industry experts.
Introducing Wanbang Xinnaokang® Ginkgo Leaf Droplets
As a first-line medication for the prevention and treatment of cardiovascular and cerebrovascular diseases, Wanbang Xinnuokang® Ginkgo Leaf Dropping Pills is listed as a National Essential Drug and a National Medical Insurance Product. It represents an innovative modern Chinese medicine formulation derived from traditional oral preparations, fully protected by proprietary intellectual property rights. Additionally, it is the flagship research focus of the academician and expert team under China’s first collaborative innovation alliance—dedicated to the development of Ginkgo Leaf Dropping Pills—which brings together medical institutions, research institutes, and pharmaceutical companies. Known for its ability to promote blood circulation, dissolve blood stasis, and unblock meridians, this product is clinically indicated for treating more than ten conditions across multiple departments, including neurology (including cerebrology), cardiology, geriatrics, and others.
A brand is not just an identifying symbol—it’s also a spiritual emblem, representing a company’s core values and serving as the ultimate embodiment of exceptional quality. More than that, a brand is about trust—and, above all, responsibility. Wanbangde Pharmaceutical Group will forge ahead with determination, staying true to our original vision and unwavering focus as we diligently cultivate high-quality pharmaceutical products. Leveraging the powerful momentum of our strong brand, we aim to ignite fresh vitality in the consumer market—empowering our brand while bringing greater health and well-being to people everywhere!
Related Recommendations